Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

DEPAKENE vs VIGAFYDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. DEPAKENE and VIGAFYDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

depakenevigafyde

Rating

72/100
New

Pharmacy pays

~$1.02 /30
—

Type

RX
RX

Active ingredient

VALPROIC ACID
VIGABATRIN

Manufacturer

Abbvie
Pyros Pharms

Dosage forms

Syrup, Capsule
Solution

Drug class

Anti-Epileptic Agent
Anti-Epileptic Agent

Boxed warning

None
Boxed warning

Treats

Alzheimer Disease, Bipolar Disorder, Epilepsy
Infantile Spasms, Complex Partial Epilepsy

Frequently asked questions

What is the difference between Depakene and Vigafyde?

Depakene contains Valproic Acid, while Vigafyde contains Vigabatrin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.